McKesson Corporation

MCKNYSEHealthcare● Active

$775.66

+$18.71(+2.47%)

Market Cap$93.2B

P/E Ratio—

52W High$999

52W Low$637

Avg Volume1.0M

Open$764.00

Beta0.32

Free Cash Flow Financials Revenue

McKesson Corporation (MCK) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

MCK · free cash flow · updated Jun 8, 2026

Core FCF metrics

MCK · FCF · TTM · margin & CAGR

Free cash flow was $5.72B for FY2026 (fiscal year ending 2026-03-31), up 9.4% year-over-year The FCF margin was 1.4%. Five-year CAGR stands at +8.0%.

FY2026 Free Cash Flow$5.72B▲ +9.4% YoY

Trailing 12M (TTM)$5.94Btrailing 4 quarters sum

FCF Margin1.4%$5.72B ÷ revenue

3-Year CAGR+7.5%FY2023 → FY2026

5-Year CAGR+8.0%FY2021 → FY2026

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

MCK · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2026Latest$6.16B(436M)$5.72B▲ +9.4%1.4%

FY2025$6.08B(859M)$5.23B▲ +44.1%1.5%

FY2024$4.31B(687M)$3.63B▼ 21.2%1.2%

FY2023$5.16B(558M)$4.60B▲ +18.0%1.7%

FY2022$4.43B(535M)$3.90B▼ 0.1%1.5%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

MCK · P/FCF · FCF yield · FCF per share

McKesson Corporation (MCK) trades at a FCF yield of 6.37% and a price-to-free-cash-flow ratio of 16.1x. FCF per share stands at $48.03, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

6.37%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$48.03

TTM FCF ÷ Shares Outstanding

Price / FCF

x16.1

Share Price ÷ FCF per Share

EV / FCF (TTM)

x16.5

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2026 · 2026-03-31

Cash flow statement summary

MCK · cash flow statement · operating / investing / financing

For FY2026, McKesson Corporation generated $6.16B in operating cash flow and spent 436M in capital expenditures, yielding $5.72B in free cash flow.

Operating Activities

+$6.16B

Cash from core business operations

2026-03-31

Investing Activities

−$3.43B

CapEx, acquisitions & investments

2026-03-31

Financing Activities

−$4.63B

Buybacks, dividends & debt

2026-03-31

FCF FormulaOperating CF ($6.16B) − |CapEx| (436M) = FCF ($5.72B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

MCK vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

McKesson CorporationYOU

MCK

$5.72B+9.4%1.4%

29%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

McKesson Corporation (MCK) reported free cash flow of $5.72B for FY2026 (fiscal year ending 2026-03-31), up 9.4% year-over-year. The FCF margin was 1.4%.

Based on available data, McKesson Corporation has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $5.72B in FY2026. The 5-year CAGR stands at +8.0%.

McKesson Corporation's FCF yield is 6.37% and price-to-FCF ratio is 16.1x for FY2026, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

MCK free cash flow · 8 questions

McKesson Corporation free cash flow was $5.72B for FY2026, up 9.4% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $5.94B.

MCK free cash flowMCK FCFMCK FCF 2026MCK free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · McKesson Corporation · McKesson Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026